Cargando…
Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC treatment. Radiofrequency (RFA) is one of the first-line therapies for early local ablation. Other local ablation techniques...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714655/ https://www.ncbi.nlm.nih.gov/pubmed/34975896 http://dx.doi.org/10.3389/fimmu.2021.792781 |